Scleral Fixation of BunnyLens With GoreTex Suture- Initial Results

February 11, 2018 updated by: DAVID HAUSER

Gore-Tex Suture and BunnyLens Scleral Fixation - Historical Retrospective Trial

This study evaluates the Visual Acuity and refraction of patients post 4-point Scleral fixation of BunnyLens (Intra Ocular Lens- IOL) with GoreTex sutures. All patients underwent secondary IOL implantation or IOL exchange during 2014-2017.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

4 point scleral fixation of PC- IOL (Posterior Chamber-PC) BunnyLens with Gore-Tex sutures is a surgical technique for implanting IOL in patients with capsular support absence, due to trauma, abnormal anterior chamber, IOL dislocation, or ciliary zonule defect.

The 4 point fixation enables to align the PC- IOL with minimal vertical and horizontal deviation;The Gore-Tex sutures maintain stable scleral fixation with no suture erosion or breakage.

Study Type

Observational

Enrollment (Anticipated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Ashkelon, Israel, 7830604
        • Recruiting
        • Barzilai University Medical Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 99 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who are capable of inform consent and are eligible according to the inclusion criteria.

Description

Inclusion Criteria:

  • patients that underwent secondary cataract surgery or IOL replacement and BunnyLens fixation with Gore-Tex sutures.

Exclusion Criteria:

  • Lack of Cooperation, death, severe physical or mental illness, patient's request to withdraw of the clinical trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
BunnyLens and Gore-Tex suture
All patients Underwent 4 point PC-IOL scleral fixation with Gore-Tex sutures
Ocular Examination
Other Names:
  • Refraction
  • Biomicroscopy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Distance Visual Acuity
Time Frame: Up to 24 months from surgery.
Degree of Visual Acuity is measured in LogMar (-0.3 to1) and by Decimal Value (0.0-2.0)
Up to 24 months from surgery.
Ocular Refraction
Time Frame: Up to 24 months from surgery.
Refraction of the Ocular surfaces, measured in sphere, cylinder and axis.
Up to 24 months from surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Slit Lamp Biomicroscopy
Time Frame: Up to 24 months from surgery.
Slit lamp examination of the anterior and posterior segments.
Up to 24 months from surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: David Hauser, MD, Barzilai University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 24, 2017

Primary Completion (ANTICIPATED)

March 24, 2018

Study Completion (ANTICIPATED)

April 24, 2018

Study Registration Dates

First Submitted

January 21, 2018

First Submitted That Met QC Criteria

February 11, 2018

First Posted (ACTUAL)

February 19, 2018

Study Record Updates

Last Update Posted (ACTUAL)

February 19, 2018

Last Update Submitted That Met QC Criteria

February 11, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 114-16-BRZ

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aphakia, Acquired

Clinical Trials on Visual Acuity

3
Subscribe